The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia

International Journal of Nursing Studies

Volumn 41, Issue 3, 2004, Pages 321-330

  Chou, Kuei Ru ^a   Chen, Ruey ^b   Lee, Jia Fu ^c   Ku, Chih Hung ^a   Lu, Ru Band ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c Armed Forces Pei Tou Hospital   (Taiwan)

Author keywords

Nicotine patch therapy; Schizophrenia; Smoking cessation

Indexed keywords

NICOTINE;

ABSTINENCE; ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SCHIZOPHRENIA; SMOKING CESSATION;

EID: 1242351546     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2003.07.001     Document Type: Article

References (41)

1. Addington J., el-Guebaly N., Addington D., Hodgins D. Readiness to stop smoking in schizophrenia. Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie. 42(1):1997;49-52.
2. Attington J., el-Guebaly N., Campbell W., Hodgins D.C., Addington D. Smoking cessation treatment for patients with schizophrenia. American Journal of Psychiatry. 155(7):1998;974-976.
3. Bohadana A., Nilsson F., Rasmussen T., Martinet Y. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation. a randomized, double-blind, placebo-controlled trial Archives of Internal Medicine. 160(20):2000;3128-3134.
4. Centers for Disease Control, 1993. 1990 Smoking: attributable mortality and years of potential life lost - Unites Sates. MMWR, 42, p. 645.
5. Centers for Disease Control and Prevention, 2000. 1998 Behavioral risk factor surveillance system summary prevalence report (online). Available at http://www.cdc.gov\nccdphp\brfss\ (revised).
6. Chen R., Ku C.H., Lu R.B., Chou K.R. The impact of smoking cessation programs on smoking-related health belief and rate of quit-smoking among schizophrenic patients. Journal of Medical Sciences. 22(5):2002;215-220.
7. Chou K.R., Liu S.Y., Chu H. The effects of support groups on caregivers of patients with schizophrenia. International Journal of Nursing Studies. 39:2002;713-722.
8. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd Edition. 1988;Lawrence Erlbaum Associates, Illsdale, NJ.
9. Cohen S., Lichtenstein E., Prochaska J.O., Rossi J.S., Gritz E.R., Carr C.R., Orleans C.T., Schoenbach V.J., Biener L., Abrams D., DiClemente C., Curry S., Marlatt G.A., Cummings K.M., Emont S.L., Giovino G., Ossip-Klein D. Debunking myths about self-quitting. evidence from 10 prospective studies of persons who attempt to quit smoking by themselves American Psychologist. 44(11):1989;1355-1365.
10. Dalack G.W., Meador-Woodruff J.H. Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia. Nicotine and Tobacco Research. 1:1999;53-57.
11. Dale L.C., Ebbert J.O., Hays J.T., Hurt R.D. Treatment of nicotine dependence. Mayo Clinical Protocol. 75(12):2000;1311-1316.
12. Davidson M., Epstein M., Burt R., Schaefer C., Whitworth G., McDonald A. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Archives of Family Medicine. 7(6):1998;569-574.
13. Fagerstrom K.O., Schneider N.G. Measuring nicotine dependence. a review of the Fagerstrom tolerance questionnaire Journal of Behavioral Medicine. 12(2):1989;159-182.
14. Farnam C.R. Zyban. a new aid to smoking cessation treatment - will it work for psychiatric patients Journal of Psychosocial Nursing. 37(2):1999;36-43.
15. Fiore M.C., Smith S.S., Jorenby D.E., Baker T.B. The effectiveness of the nicotine patch for smoking cessation. a meta-analysis JAMA: The Journal of the American Medical Association. 271(24):1994;1940-1947.
16. Gjerris A., Bech P., Bojholm S., Bolwig T.G., Kramp P., Clemmesen L., Andersen J., Jensen E., Rafaelsen O.J. The hamilton anxiety scale. evaluation of homogeneity and inter-observer reliability in patients with depressive disorders Journal of Affective Disorders. 5(2):1983;163-170.
17. Hartman N., Leong G.G., Glynn S.M., Wilkins J.N., Jarvik M.E. Transdermal nicotine and smoking behavior in psychiatric patients. American Journal of Psychiatry. 148:1991;374-375.
18. Hays J.T., Croghan I.T., Schroeder D.R., Offord K.P., Hurt R.D., Wolter T., Nides M.A., Davidson M. Over-the-counter nicotine patch therapy for smoking cessation. results from randomized, double-blind, placebo-controlled, and open label trials American Journal of Public Health. 89(11):1999;1701-1707.
19. Herdman, R., Hewitt, M., Laschober, M., 1993. Smoking-related deaths and financial costs: Office of Technology Assessment estimates for 1990. Congress of the United States, Office of Technology Assessment.
20. Hughes J.R., Hatsukami D.K., Mitchell J.E., Dahlgren L.A. Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry. 143(8):1986;993-997.
21. Hurt R.D., Dale L.C., Fredrickson P.A., Caldwell C.C., Lee G.A., Offord K.P., Lauger G.G., Marusic Z., Neese L.W., Lundberg T.G. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. one-year outcome and percentage of nicotine replacement JAMA: the Journal of the American Medical Association. 271(8):1994;595-600.
22. Jorenby D.E., Leischow S.J., Nides M.A., Rennard S.I., Johnston J.A., Hughes A.R., Smith S.S., Muramoto M.L., Daughton D.M., Doan K., Fiore M.C., Baker T.B. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. The New England Journal of Medicine. 340(9):1999;685-691.
23. Joseph A.M., Norman S.M., Ferry L.H., Prochazka A.V., Westman E.C., Steele B.G., Sherman S.E., Cleveland M., Antonnucio D.O., Hartman N., McGovern P.G. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. The New England Journal of Medicine. 335(24):1996;1792-1798.
24. Lohr J.B., Flynn K. Smoking and schizophrenia. Schizophrenia Research. 8(2):1992;93-102.
25. Masterson E., O'Shea B. Smoking and malignancy in schizophrenia. British Journal of Psychiatry. 145:1984;429-432.
26. Menza M.A., Grossman N., Van Horn M., Cody R., Forman N. Smoking and movement disorders in psychiatric patients. Biological Psychiatry. 30(2):1991;109-115.
27. Morlan K.K., Tan S.Y. Comparison of Brief Psychiatric Rating Scale and the Brief Symptom Inventory. Journal of Clinical Psychology. 54(7):1998;885-894.
28. Murray R.P., Connett J.E., Lauger G.G., Voelker H.T. Error in smoking measures. effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking American Journal of Public Health. 83(9):1993;1251- 1257.
29. O'Farrell T.J., Connors G.J., Upper D. Addictive behaviors among hospitalized schizophrenic patients. Addictive Behaviors. 8(4):1983;329-333.
30. Radzius A., Moolchan E.T., Henningfield J.E., Heishman S.J., Gallo J.J. A factor analysis of the Fagerstrom tolerance questionnaire. Addictive Behavior. 26(2):2001;303-310.
31. Resnick M.P., Bosworth E.E. A smoke-free psychiatric unit. Hospital Community Psychiatry. 40(5):1989;525-527.
32. Sachs D.P., Sawe U., Leischow S.J. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Archives of Internal Medicine. 153(16):1993;1881-1890.
33. Silagy, C., Mant, D., Fowler, G., Lodge, M., 1994. The effectiveness of nicotine replacement therapies in smoking cessation. Online Journal of Current Clinical Trials, Doc No. 113.
34. Thorsteinn B., Jon G.L., Ingileif O., Gunnar G., Ake W. Nicotine nasal spray with nicotine patch for smoking cessation. randomized trial with six year follow-up British Medical Journal. 318(7179):1999;285-288.
35. Thorward S.R., Birnbaum S. Effects of a smoking ban on a general hospital psychiatric unit. General Hospital Psychiatry. 11(1):1989;63-67.
36. Tidey J.W., O'Neill S.C., Higgins S.T. Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Experimental and Clinical Psychopharmacology. 10(3):2002;241-247.
37. Van Dongen C.J. Smoking and persistent mental illness. an exploratory study Journal of Psychosocial Nursing. 37(11):1999;26-34.
38. Van Dongen C.J., Kriz P., Fox K.A., Haque I. A quit smoking group. pilot study Journal of Psychosocial Nursing. 37(12):1999;31-36.
39. Wagner B., Wolf G.K., Ulmar K. Does smoking reduce the risk of neuroleptic Parkinsonoids? Pharmacopsychiatry. 21(6):1988;302-303.
40. Westman E.C., Levin E.D., Rose J.E. The nicotine patch in smoking cessation. a randomized trial with telephone counseling Archives of Internal Medicine. 153(16):1993;1917-1923.
41. Ziedonis D.M., George T.P. Schizophrenia and nicotine use. report of a pilot smoking cessation program and review of Neurobiological and clinical issues Schizophrenia Bulletin. 23(2):1997;247-254.